These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16610118)

  • 1. Dual HIV infection.
    Cheonis N
    BETA; 2006; 18(2):36-40. PubMed ID: 16610118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clades of HIV: their origins and clinical significance.
    Stebbing J; Moyle G
    AIDS Rev; 2003; 5(4):205-13. PubMed ID: 15011999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the human immunodeficiency virus.
    Brun-Vézinet F; Charpentier C
    Med Mal Infect; 2013 May; 43(5):177-84. PubMed ID: 23628423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging infectious diseases: new and resistant strains of HIV.
    Paul SM; Costa SJ; Cross H; Pierce M; Pizutti W; Morgan DH; Ziskin LZ
    N J Med; 1997 Jun; 94(6):43-7. PubMed ID: 9195842
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.
    Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J
    Virology; 1999 Sep; 262(2):312-20. PubMed ID: 10502510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [History and current status of laboratory research: the mysteries of HIV are being discovered step by step after an exceptional international research mobilization].
    Wahren B
    Lakartidningen; 1991 Nov; 88(48):4132-4, 4137. PubMed ID: 1956252
    [No Abstract]   [Full Text] [Related]  

  • 8. The genetic variability of HIV-1 and its implications.
    Peeters M
    Transfus Clin Biol; 2001 Jun; 8(3):222-5. PubMed ID: 11499964
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.
    Rodés B; Toro C; Jiménez V; Soriano V
    Clin Infect Dis; 2005 Jul; 41(2):e19-21. PubMed ID: 15983906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The status of and outlook for the creation of new preparations for the therapy and prevention of HIV infection and AIDS].
    Ivanitskaia LP; Nosik DN; Bibikova MV; Iakushkina NI; Spiridonova IA; Grigor'ev VB; Lobach OA
    Antibiot Khimioter; 1999; 44(10):39-45. PubMed ID: 10635421
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
    Tebit DM; Nankya I; Arts EJ; Gao Y
    AIDS Rev; 2007; 9(2):75-87. PubMed ID: 17694675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
    Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
    J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in the European HIV/AIDS epidemic: a perspective from Italy.
    Madeddu G; Rezza G; Mura MS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):25-36. PubMed ID: 19622055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.
    Hu DJ; Dondero TJ; Rayfield MA; George JR; Schochetman G; Jaffe HW; Luo CC; Kalish ML; Weniger BG; Pau CP; Schable CA; Curran JW
    JAMA; 1996 Jan; 275(3):210-6. PubMed ID: 8604174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
    Landman R; Damond F; Gerbe J; Brun-Vezinet F; Yeni P; Matheron S
    AIDS; 2009 Jan; 23(3):426-8. PubMed ID: 19114866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG.
    Fischetti L; Opare-Sem O; Candotti D; Sarkodie F; Lee H; Allain JP
    J Med Virol; 2004 Jun; 73(2):158-66. PubMed ID: 15122787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    AIDS; 2014 Apr; 28(7):949-57. PubMed ID: 24812673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
    Bruhn CA; Gilbert MT
    Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
    [No Abstract]   [Full Text] [Related]  

  • 19. Coming and going: some aspects of care for migrants with HIV in the UK.
    Anderson J
    J Infect; 2008 Jul; 57(1):11-5. PubMed ID: 18541306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Nowroozalizadeh S; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    N Engl J Med; 2012 Jul; 367(3):224-32. PubMed ID: 22808957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.